The short version
The peptide that arrives at your door has a real cost: the active ingredient, the sterile compounding, the dispensing, the shipping, and the prescriber's evaluation that authorized it. That cost is roughly the same whether it's billed inside a membership or invoiced per protocol. What differs is how the platform recovers its other operating costs.
Membership models recover them through a recurring fee plus a markup on the medication. Per-protocol models recover them inside the visit fee and the prescription. The peptide itself doesn't cost more in one model — it just gets allocated cost differently. For a buyer with a defined protocol, the per-protocol allocation usually nets lower.
Why membership models mark up the peptide
If a platform charges a recurring fee, the membership has to feel like it covers a lot — coaching, labs, app access, "free" consults. To make that math work without raising the headline membership price, the medication gets marked up to subsidize the soft costs. A peptide that a 503A pharmacy dispenses for one price gets billed to the member at two or three times that.
This isn't always disclosed in the same place as the membership fee, which is what makes it feel like a surprise. It's not that the platform is hiding the markup — it's that the membership headline talks about access, and the medication invoice arrives separately. A buyer reading both at once will see the gap. A buyer reading them weeks apart often won't.
The peptide costs about the same to make. The difference is whose other costs ride along with it.
Where the markup falls short for a different buyer
For a buyer running a single peptide for four months, the markup compounds: the membership fee + the marked-up medication often exceeds what a per-protocol platform charges for the same prescription evaluated by the same kind of clinician and dispensed by the same kind of 503A pharmacy. The difference isn't quality — it's allocation.
The honest read on most concierge or membership pricing: it's not a bad deal for someone using the full breadth of the membership. It's a bad deal for someone who only wants the prescription.
What Boswell is built for
Boswell prices per protocol. The clinical evaluation is its own line. The medication is its own line, billed at the pharmacy's rate without markup. If your protocol is BPC-157 for tendon recovery, you see the cost of the BPC-157 prescription — not a peptide line item subsidizing somebody else's bundled coaching.
That works because Boswell's overhead structure is different: there's no membership-team payroll between prescriptions. The clinician's time is paid for inside the evaluation that authorizes your prescription. Read how it works for the sequence, and peptide therapy without a membership for the model comparison.
Questions worth asking before either
- What does the medication actually cost the pharmacy to dispense, and what am I being billed?
- Is there a markup on the prescription itself, or is the platform fee separate?
- What's my all-in cost for a four-month protocol — visit + medication + shipping?
- If I want to renew but skip the coaching, can I?
- Is the pharmacy disclosed up front so I can compare?
Sources